Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Williams

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Physiology|June 27, 2017
Effects of Dietary Nitrate Supplementation on Physiological Responses, Cognitive Function, and Exercise Performance at Moderate and Very-High Simulated AltitudeOliver M Shannon, Lauren Duckworth, Matthew J Barlow, et al.
British Journal of Haematology|October 11, 2021
CD4<sup>+</sup> T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expressionMadeleine L Stimpson, Julia S Wolf, Emily L Williams, et al.
Blood|November 15, 2013
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificityAndrew T Vaughan, Chisako Iriyama, Stephen A Beers, et al.
Journal of Vision|October 20, 2023
Temporal dynamics of normalization reweightingDaniel H Baker, Daniela Marinova, Richard Aveyard, et al.
Plos One|February 14, 2020
Intravenous indocyanine green dye is insufficient for robust immune cell labelling in the human retinaOliver H Bell, Ester Carreño, Emily L Williams, et al.
European Journal of Immunology|July 5, 2012
Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B)Emily L Williams, Alison L Tutt, Ruth R French, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalizationEmily L Williams, Alison L Tutt, Stephen A Beers, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Fcγ receptor dependency of agonistic CD40 antibody in lymphoma therapy can be overcome through antibody multimerizationAnn L White, Lang Dou, H T Claude Chan, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Physiology|June 27, 2017
Effects of Dietary Nitrate Supplementation on Physiological Responses, Cognitive Function, and Exercise Performance at Moderate and Very-High Simulated AltitudeOliver M Shannon, Lauren Duckworth, Matthew J Barlow, et al.
British Journal of Haematology|October 11, 2021
CD4<sup>+</sup> T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expressionMadeleine L Stimpson, Julia S Wolf, Emily L Williams, et al.
Blood|November 15, 2013
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificityAndrew T Vaughan, Chisako Iriyama, Stephen A Beers, et al.
Journal of Vision|October 20, 2023
Temporal dynamics of normalization reweightingDaniel H Baker, Daniela Marinova, Richard Aveyard, et al.
Plos One|February 14, 2020
Intravenous indocyanine green dye is insufficient for robust immune cell labelling in the human retinaOliver H Bell, Ester Carreño, Emily L Williams, et al.
European Journal of Immunology|July 5, 2012
Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B)Emily L Williams, Alison L Tutt, Ruth R French, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalizationEmily L Williams, Alison L Tutt, Stephen A Beers, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Fcγ receptor dependency of agonistic CD40 antibody in lymphoma therapy can be overcome through antibody multimerizationAnn L White, Lang Dou, H T Claude Chan, et al.
Pageof 5